CSF3 and breast cancer: Researchers demonstrated in a murine breast cancer model that tumor-derived G-CSF induces myeloid differentiation reprogramming in the bone marrow, thereby increasing the number of TME-infiltrating N2-polarized TANs with T-cell suppressive functions (Giese et al., 2019).